Torsten Goesch – Rosetta Capital

Skip to content

About us
Our focus
Case studies
Our people
Our portfolio
Contact

Menu

About us
Our focus
Case studies
Our people
Our portfolio
Contact

About us
Our focus
Case studies
Our people
Our portfolio
Contact

Menu

About us
Our focus
Case studies
Our people
Our portfolio
Contact

Torsten Goesch

Partner

Torsten Goesch joined Rosetta in 2002. He combines medical training with more than 25 years of operational and deal-making experience in the life science sector. Previously, he held senior operational roles at Biogen and Merck KGa. Torsten holds a MD PhD from the Heinrich Heine University in Dusseldorf and an MBA from the Kellogg School of Management in Chicago.

Torsten has played a key leadership role on the Boards of exited portfolio companies such as Cytochroma, Enobia and STI Technologies. He continues to serve on the Boards of Dilafo and EyeSense.

Meet more of our people

Ken MacLeod

Partner

Michael Forer

Partner

Torsten Goesch

Partner

Terms & conditions

Cookie policy

Privacy policy

Registered in England No. 3941653 | VAT No. GB 765 3567 96

© 2017 Rosetta Capital Limited | Authorised and regulated by the Financial Conduct Authority

Website by Instinctif Partners

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Powered by GDPR Cookie Compliance

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.